ESAM Reduces Anti-HER2 Therapy Sensitivity in Breast Cancer via mTOR Activation
Elevated ESAM expression promotes resistance to anti-HER2 therapy in HER2-positive breast cancer by stabilizing Calnexin and activating the mTOR pathway.
Elevated ESAM expression promotes resistance to anti-HER2 therapy in HER2-positive breast cancer by stabilizing Calnexin and activating the mTOR pathway.
A comprehensive review establishes that post-traumatic epilepsy emerges from progressive, time-dependent failures across hippocampal inhibition, structural circuit wiring, and astrocytic ...
A hypothesis-generating review proposes that the mitochondrial contact site and cristae organizing system acts as a structural checkpoint linking crista ...
A comprehensive scientific review reveals that while cellular degradation pathways influence melanocyte biology, no clinical evidence proves altering autophagy directly ...
Elevated JPT1 expression in head and neck squamous cell carcinoma correlates with poorer overall patient survival and impairs cellular mitophagy ...
A small exploratory study found 15 cell-free miRNAs in plasma that differed between patients whose first unprovoked seizure remained isolated ...
A preclinical study reports that the organoselenium compound ebselen improved mitochondrial respiration, ATP production and exercise capacity in yeast, human ...
A new study reports that irradiation stabilizes EZH2 in glioblastoma, driving H3K27me3-mediated DEPTOR repression and mTOR activation, and that EZH2 ...
A Mendelian randomization study combined with tumor database and cell experiments links genetically higher serum uric acid to lower gastric ...
A cell study finds silk fibroin from silkworm cocoons enlarged myotubes and activated mTOR signaling in C2C12 mouse myoblasts.
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine